Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection

Journal of Infectious Diseases

Volumn 205, Issue 1, 2012, Pages 44-53

  Ling, Man To ^a   Tu, Wenwei ^a   Han, Yan ^a   Mao, Huawei ^a   Chong, Wai Po ^a   Guan, Jing ^a   Liu, Ming ^b   Lam, Kwok Tai ^a   Law, Helen K W ^a   Peiris, J S Malik ^a   Takahashi, K ^c   Lau, Yu Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MANNOSE BINDING LECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVIAN INFLUENZA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; IN VITRO STUDY; INFLAMMATION; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H9N2; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; UPREGULATION; VIRUS STRAIN; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; CHEMOKINES; CYTOKINES; INFLAMMATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; LUNG; MANNOSE-BINDING LECTIN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; VIRAL LOAD; WEIGHT LOSS;

EID: 84555189246     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir691     Document Type: Article

References (50)

1. World Health Organization. Pandemic (H1N1) 2009dupdate 112. http://www.who.int/csr/don/2010-08-06/en/index.html. Accessed 7 February 2011.
2. World Health Organization. Pandemic (H1N1) 2009dbriefing note. http://www.who.int/csr/disease/swineflu/notes/briefing-20100810/en/index.html. Accessed 07 February 2011.
3. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325:197-201.
4. Tu W, Mao H, Zheng J, et al. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol 2010; 84:6527-35.
5. Butt KM, Smith GJ, Chen H, et al. Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol 2005; 43:5760-7. (Pubitemid 41612358)
6. Peiris M, Yuen KY, Leung CW, et al. Human infection with influenza H9N2. Lancet 1999; 354:916-7. (Pubitemid 29424025)
7. Guan Y, Shortridge KF, Krauss S, et al. H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J Virol 2000; 74:9372-80.
8. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science 1999; 284:1313-8. (Pubitemid 29289650)
9. Takahashi K, Ip WE, Michelow IC, Ezekowitz RA. The mannosebinding lectin: a prototypic pattern recognition molecule. Curr Opin Immunol 2006; 18:16-23. (Pubitemid 43049643)
10. Thiel S, Vorup-Jensen T, Stover CM, et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997; 386:506-10. (Pubitemid 27164078)
11. Kuhlman M, Joiner K, Ezekowitz RA. The human mannose-binding protein functions as an opsonin. J Exp Med 1989; 169:1733-45. (Pubitemid 19126829)
12. Ip WK, Chan KH, Law HK, et al. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005; 191:1697-704. (Pubitemid 40656758)
13. Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 1997; 314:1229-32. (Pubitemid 27173906)
14. Hartshorn KL, Sastry K, White MR, et al. Human mannose-binding protein functions as an opsonin for influenza A viruses. J Clin Invest 1993; 91:1414-20. (Pubitemid 23127341)
15. Anders EM, Hartley CA, Reading PC, Ezekowitz RA. Complementdependent neutralization of influenza virus by a serum mannosebinding lectin. J Gen Virol 1994; 75:615-22. (Pubitemid 24091818)
16. Kase T, Suzuki Y, Kawai T, et al. Human mannan-binding lectin inhibits the infection of influenza A virus without complement. Immunology 1999; 97:385-92. (Pubitemid 29314633)
17. Reading PC, Morey LS, Crouch EC, Anders EM. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol 1997; 71:8204-12. (Pubitemid 27446395)
18. Job ER, Deng YM, Tate MD, et al. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J Immunol 2010; 185:4284-91.
19. Kaufmann A, Salentin R, Meyer RG, et al. Defense against influenza A virus infection: essential role of the chemokine system. Immunobiology 2001; 204:603-13. (Pubitemid 34134174)
20. Veckman V, Osterlund P, Fagerlund R, Melen K, Matikainen S, Julkunen I. TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology 2006; 345:96-104. (Pubitemid 43107575)
21. Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, Klein NJ. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis 2001; 184:1152-62. (Pubitemid 33010468)
22. Nadesalingam J, Dodds AW, Reid KB, Palaniyar N. Mannose-binding lectin recognizes peptidoglycan via the N-acetyl glucosamine moiety, and inhibits ligand-induced proinflammatory effect and promotes chemokine production by macrophages. J Immunol 2005; 175:1785-94. (Pubitemid 41023083)
23. Chang WC, White MR, Moyo P, et al. Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection. BMC Immunol 2010; 11:64.
24. Mao H, Tu W, Qin G, et al. Influenza virus directly infects human natural killer cells and induces cell apoptosis. J Virol 2009; 83:9215-22.
25. Zhou J, Law HK, Cheung CY, Ng IH, Peiris JS, Lau YL. Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses. J Infect Dis 2006; 194:61-70.
26. Mao H, TuW, Liu Y, et al. Inhibition of human natural killer cell activity by influenza virions and hemagglutinin. J Virol 2010; 84:4148-57.
27. Shi L, Takahashi K, Dundee J, et al. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 2004; 199:1379-90. (Pubitemid 38685729)
28. Goodman AG, Fornek JL,Medigeshi GR, et al. P58(IPK): a novel "CIHD" member of the host innate defense response against pathogenic virus infection. PLoS Pathog 2009; 5:e1000438.
29. Tu W, Zheng J, Liu Y, et al. The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a {gamma}{delta} T cell population in humanized mice. J Exp Med 2011; 208:1511-22.
30. Summerfield JA, Taylor ME. Mannose-binding proteins in human serum: identification of mannose-specific immunoglobulins and a calcium-dependent lectin, of broader carbohydrate specificity, secreted by hepatocytes. Biochim Biophys Acta 1986; 883:197-206. (Pubitemid 16027981)
31. Hartley CA, Reading PC, Ward AC, Anders EM. Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice. Arch Virol 1997; 142:75-88. (Pubitemid 27050433)
32. Dinarello CA. Role of interleukin-1 in infectious diseases. Immunol Rev 1992; 127:119-46.
33. Schmitz N, Kurrer M, Bachmann MF, Kopf M. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J Virol 2005; 79:6441-8. (Pubitemid 40617247)
34. Pang IK, Iwasaki A. Inflammasomes as mediators of immunity against influenza virus. Trends Immunol 2011; 32:34-41.
35. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87:2095-147. (Pubitemid 26086851)
36. Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci USA 2007; 104:12479-81. (Pubitemid 47206163)
37. Szretter KJ, Gangappa S, Lu X, et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 2007; 81:2736-44. (Pubitemid 46447038)
38. Julkunen I, Melen K, Nyqvist M, Pirhonen J, Sareneva T, Matikainen S. Inflammatory responses in influenza A virus infection. Vaccine 2000; 19(Suppl 1):S32-7. (Pubitemid 32121717)
39. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234:470-4. (Pubitemid 17181429)
40. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330:662-4. (Pubitemid 18005583)
41. Hagau N, Slavcovici A, Gonganau DN, et al. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care 2010; 14:R203.
42. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, Matikainen S. Molecular pathogenesis of influenza A virus infection and virusinduced regulation of cytokine gene expression. Cytokine Growth Factor Rev 2001; 12:171-80. (Pubitemid 32588143)
43. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 1998; 101:643-9. (Pubitemid 28084248)
44. McKinstry KK, Strutt TM, Buck A, et al. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against highdose challenge. J Immunol 2009; 182:7353-63.
45. Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010; 181:72-9.
46. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 2009; 13:R201.
47. Cheung CY, Poon LL, Lau AS, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002; 360:1831-7. (Pubitemid 35449422)
48. Geiler J, Michaelis M, Sithisarn P, Cinatl J Jr. Comparison of proinflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses. Med Microbiol Immunol 2011; 200:53-60.
49. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338:436-45. (Pubitemid 28135672)
50. Ip WK, Takahashi K, Moore KJ, Stuart LM, Ezekowitz RA. Mannosebinding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome. J Exp Med 2008; 205:169-81. (Pubitemid 351185724)